Trials on blood pressure-lowering and secondary stroke prevention

American Journal of Cardiology

Volumn 91, Issue 10 SUPPL. 1, 2003, Pages 3-8

  Chalmers, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; PERINDOPRIL; RAMIPRIL;

ADD ON THERAPY; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY STENT; COUGHING; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; HYPOTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; META ANALYSIS; MONOTHERAPY; MORBIDITY; OUTCOMES RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZATION; RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

EID: 0038777175     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00226-1     Document Type: Review

References (15)

1. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary heart disease Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias . Lancet. 335:1990;765-774.
2. Blood pressure, cholesterol, and stroke in Eastern Asia. Lancet. 352:1998;1801-1807.
3. MacMahon S., Rodgers A. Blood pressure, antihypertensive treatment and stroke risk. J Hypertens. 12:(suppl 10):1994;S5-S14.
4. Neal B., MacMahon S., Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs results of prospectively designed overviews of randomised trials: Blood Pressure Lowering Treatment Trialists' Collaboration . Lancet. 356:2000;1955-1964.
5. Hansson L., Lindholm L.H., Ekbom T., Dahlöf B., Lanke J., Schersten B., Wester P.O., Hedner T., de Faire U. Randomised trial of old and new antihypertensive drugs in elderly patients cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study . Lancet. 354:1999;1751-1756.
6. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38, UK Prospective Diabetes Study Group . BMJ. 317:1998;703-713.
7. Kannel W.B., Wolf P.A., Benjamin E.J., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation population-based estimates . Am J Cardiol. 82:(suppl):1998;2N-9N.
8. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., et al., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342:2000;145-153.
9. Hankey G.J., Warlow C.P. Treatment and secondary prevention of stroke evidence, costs, and effects on individuals and populations . Lancet. 354:1999;1457-1463.
10. Rodgers A., MacMahon S., Gamble G., Slattery J., Sandercock P., Warlow C. Blood pressure and risk of stroke in patients with cerebrovascular disease the United Kingdom Transient Ischaemic Attack Collaborative Group . BMJ. 313:1996;147.
11. Gueyffier F., Boissel J.P., Boutitie F., Pocock S., Coope J., Cutler J., Ekbom T., Fagard R., Friedman L., Kerlikowske K., et al. Effect of antihypertensive treatment in patients having already suffered from stroke gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators . Stroke. 28:1997;2557-2562.
12. Blood pressure lowering for the secondary prevention of stroke rationale and design for PROGRESS. PROGRESS Management Committee: Perindopril Protection Against Recurrent Stroke Study . J Hypertens Suppl. 14:(suppl):1996;S41-S45. discussion S45-S46.
13. Weidmann P., de Courten M., Ferrari P., Bohlen L. Serum lipoproteins during treatment with antihypertensive drugs. J Cardiovasc Pharmacol. 22:(suppl 6):1993;S98-S105.
14. Matheson A.J., Cheer S.M., Goa K.L. Perindopril/indapamide 2/0.625 mg/day a review of its place in the management of hypertension . Drugs. 61:2001;1211-1229.
15. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.